MeiraGTx Holdings plc share price logo

MeiraGTx Holdings plc

NASDAQ: MGTX

Small Cap

$9.71

-0.04

(-0.41%)

as on

MeiraGTx Holdings plc Stock Performance

as on June 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $9.51
    $9.93
    downward going graph

    2.06%

    Downside

    2.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.07
    $11.85
    downward going graph

    37.49%

    Downside

    22.04%

    Upside

    downward going graph

MeiraGTx Holdings plc share price movements today

Previous Close
$9.75
Open
$9.63
Volume
572.0K
Day's Low - High
$9.51 - $9.93
52 Week Low - High
$6.07 - $11.85

MeiraGTx Holdings plc Historical Returns

1 Month Return
+ 3.3 %
3 Month Return
+ 26.93 %
1 Year Return
+ 53.4 %
3 Year Return
+ 29.29 %
5 Year Return
-35.31 %

MeiraGTx Holdings plc Stock Fundamentals & Key Indicators

Check MeiraGTx Holdings plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$902.9M

EPS (TTM)

-1.4667

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-92.7M

Revenue (TTM)

79.8M

Profit Margin

-151.12%

Return On Equity TTM

-368.19%

MeiraGTx Holdings plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MeiraGTx Holdings plc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MeiraGTx Holdings plc image
MeiraGTx Holdings plc
BUY$902.9M-35.31%NA-151.12%NA
Alnylam Pharmaceuticals Common Stock image
Alnylam Pharmaceuticals Common Stock
BUY$38.4B63.66%72.4912.55%NA
Vertex PharmaceuticalsCommon Stock image
Vertex PharmaceuticalsCommon Stock
BUY$114.3B140.59%26.7335.51%NA
Regeneron Pharmaceuticals Common Stock image
Regeneron Pharmaceuticals Common Stock
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for MeiraGTx Holdings plc Stock including INR - Dollar returns

The MeiraGTx Holdings plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

MeiraGTx Holdings plc investment value today

Current value as on today

₹1,68,951

Returns

₹68,951

(+68.95%)

Returns from MeiraGTx Holdings plc Stock

₹53,397 (+53.4%)

Dollar Impact

₹15,554 (+15.55%)

Analyst Recommendation on MeiraGTx Holdings plc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for MeiraGTx Holdings plc. Average target price of $28.25

MeiraGTx Holdings plc Share Price Target

Get share price movements and forecasts by analysts on MeiraGTx Holdings plc.

What analysts predicted

65.63%UPSIDE

Target Price

$28.25

Current Price

$9.71

Analyzed by

11 Analysts

Target

$28.25

MeiraGTx Holdings plc target price $28.25, a slight upside of 65.63% compared to current price of $9.71. According to 11 analysts rating.

Indian Investors' Interest in MeiraGTx Holdings plc Stock

Search interest for MeiraGTx Holdings plc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

MeiraGTx Holdings plc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
0
0
10
21
1
3
0
75
0
Gross Profit
-1
-2
0
-1
9
0
1
0
74
-2
Operating Income
-43
-46
-45
-40
-31
-41
-44
-46
26
-40
EBITDA
27
-13
-42
-32
-33
-33
-32
-44
21
-40
Interest Expense
3
3
3
3
3
3
3
3
3
2
Depreciation
3
3
3
3
2
3
3
3
3
3
Income Before Tax
20
-20
-48
-39
-39
-39
-38
-50
15
-46
Income Tax Expense
-8
3
-
-
-3
-
-
-
-
-
Net Income
20
-20
-48
-39
-39
-39
-38
-50
15
-46
Net Profit Margin
990.93%
-2932.86%
-17241.13%
-360.49%
-184.19%
-2075.86%
-1051.07%
-12320.24%
20.02%
-15806.48%

MeiraGTx Holdings plc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
13
15
37
15
14
33
81
Gross Profit
0
0
-2
13
15
37
15
14
9
76
Operating Income
-20
-31
-78
-58
-62
-72
-116
-137
-164
-105
EBITDA
-19
-31
-78
-52
-53
-71
-116
-57
-121
-89
Interest Expense
0
0
0
0
0
0
4
13
13
12
Depreciation
-
0
2
2
4
7
8
12
12
12
Income Before Tax
-19
-31
-83
-54
-57
-79
-129
-84
-147
-114
Income Tax Expense
0
0
0
-2
-4
-7
13
13
-
-
Net Income
-19
-31
-82
-54
-57
-79
-129
-84
-147
-114
Net Profit Margin
0.00%
0.00%
0.00%
-411.87%
-372.63%
-211.03%
-814.16%
-599.46%
-444.10%
-140.31%

MeiraGTx Holdings plc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-20
-48
-39
-39
-39
-38
-50
-192
-46
Operating Cash Flow
-36
-19
-25
-23
-36
-43
-12
46
17
Investing Cash Flow
27
-1
-1
-1
-1
0
0
-1
-2
Financing Cash Flow
-1
1
49
4
1
5
0
5
-10
Change in Cash
-10
-19
24
-19
-37
-34
-17
51
5

MeiraGTx Holdings plc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-82
-54
-57
-79
-129
-84
-147
-114
Operating Cash Flow
-18
-58
20
-63
-10
-73
-105
-104
-46
Investing Cash Flow
-10
-11
-9
-37
-61
-44
34
23
-4
Financing Cash Flow
19
130
148
82
1
95
84
54
12
Change in Cash
-9
59
159
-17
-71
-22
15
-24
-37

Global Institutional Holdings in MeiraGTx Holdings plc

Funds
Holdings
Long Focus Capital Management, LLC
0.57%
Hennion & Walsh Asset Management Inc
0.14%
The Goldman Sachs Group Inc
0.48%
Johnson & Johnson
7.17%
Adage Capital Partners Gp LLC
4.32%
See all

MeiraGTx Holdings plc News & Key Events

  • img

    Today's Timeline - 10 November

    Mon, 05:30 PM

    -

    MeiraGTx collaborates with Eli Lilly to develop AAV-AIPL1 for LCA4, receiving $75 million upfront and potential milestone payments exceeding $400 million.

Insights on MeiraGTx Holdings plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MGTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MGTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MGTX stock has moved up by 6.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 75.36M → 293.0K (in $), with an average decrease of 99.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.08M → -46.31M (in $), with an average decrease of 407.0% per quarter

About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase ½ clinical trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.
OrganisationMeiraGTx Holdings plc
Headquarters655 Third Avenue, New York, NY, United States, 10017
IndustryBiotechnology
CEODr. Alexandria Forbes Ph.D.
E-voting on sharesClick here to vote

Key Management of MeiraGTx Holdings plc

Name

Title

Dr. Alexandria Forbes Ph.D.

CEO, President & Director

Ms. Christine Elise Sheehy

Senior Vice President of Global Integration

Dr. David Rubinstein Ph.D.

Senior Vice President of Business Development

Dr. Tassos Georgiadis Ph.D.

Senior Vice President of Discovery & Preclinical Development

Mr. Tim Randall

Senior Vice President of Risk & Internal Controls

Mr. Richard Brian Giroux B.A.

COO & CFO

Dr. Robert K. Zeldin M.D.

Chief Medical Officer

Mr. Robert J. Wollin J.D.

General Counsel & Secretary

Dr. Stuart Naylor Ph.D.

Chief Scientific Officer of Ophthalmology

Dr. Michel Michaelides F.A.C.S., M.D., MBBS

Head of Clinical Ophthalmology

FAQs

What is MeiraGTx Holdings plc share price today?

MeiraGTx Holdings plc share price today is $9.71 as on at the close of the market. MeiraGTx Holdings plc share today touched a day high of $9.93 and a low of $9.51.

What is the 52 week high and 52 week low for MeiraGTx Holdings plc share?

MeiraGTx Holdings plc share touched a 52 week high of $11.85 on and a 52 week low of $6.07 on . MeiraGTx Holdings plc stock price today i.e. is closed at $9.71,which is 18.06% down from its 52 week high and 59.97% up from its 52 week low.

What is MeiraGTx Holdings plc's market capitalisation today?

MeiraGTx Holdings plc market capitalisation is $0.00T as on .

How to invest in MeiraGTx Holdings plc Stock (MGTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MeiraGTx Holdings plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MeiraGTx Holdings plc Shares that will get you 0.1545 shares as per MeiraGTx Holdings plc share price of $9.71 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy MeiraGTx Holdings plc Stock (MGTX) from India?

Indian investors can start investing in MeiraGTx Holdings plc (MGTX) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in MeiraGTx Holdings plc stock (as per the Rupee-Dollar exchange rate as on ). Based on MeiraGTx Holdings plc share’s latest price of $9.71 as on June 17, 2026 at 8:45 am IST, you will get 1.0299 shares of MeiraGTx Holdings plc. Learn more about fractional shares .

What are the returns that MeiraGTx Holdings plc has given to Indian investors in the last 5 years?

MeiraGTx Holdings plc stock has given -35.31% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?